The 2016 United Nations political declaration on antimicrobial resistance (AMR) acknowledged the importance of delinking the cost of investment in research and development on AMR from the price and volume of sales to facilitate equitable and affordable access to new products and encouraged governments to explore innovative approaches.<\/p>
<\/p>
It is critical that the National Health Service makes the best use of its resources. Any payment model must therefore be based on a robust evaluation of the value that a new antimicrobial product brings to patients and the public as a whole. The assessment of how much value a new antibiotic brings is highly complex and will vary considerably from one product to another.<\/p>
<\/p>
In the United Kingdom, NHS England and the National Institute for Health and Care Excellence (NICE) are leading work to test innovative models that pay companies based primarily on a NICE led health technology assessment of their value to the NHS as opposed to the volumes used. This has the potential to both promote good antimicrobial stewardship and provide a much-needed incentive for the development of new antimicrobial agents that will, over time, provide value for the NHS.<\/p>
<\/p>
The test will be subject to robust evaluation before considering any wider change to purchasing policy. The UK represents only a small part of the global market for these drugs and we want to send a signal to the rest of the world that there are workable models to achieve the right sort of incentives for these vital medicines.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"} } , "answeringMemberConstituency" : {"_value" : "Winchester"} , "answeringMemberPrinted" : {"_value" : "Steve Brine"} , "dateOfAnswer" : {"_value" : "2019-03-11", "_datatype" : "dateTime"} , "groupedQuestionUIN" : {"_value" : "228682"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1082134/answer/previousversion/106925", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"} } , "answeringMemberConstituency" : {"_value" : "Winchester"} , "answeringMemberPrinted" : {"_value" : "Steve Brine"} } , "questionFirstAnswered" : [{"_value" : "2019-03-11T18:32:38.25Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2019-03-05", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Antimicrobials: Prices"} , "houseId" : {"_value" : "1"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"} } ], "questionText" : "To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential merits of using models that de-link the cost of research and development from the price of the final product and the volume of sales, as set out in the 2016 UN Political Declaration of the High-Level Meeting of the General Assembly on antimicrobial resistance, to ensure that new diagnostics, medicines and tools created are accessible and affordable.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4385", "label" : {"_value" : "Biography information for Dr Philippa Whitford"} } , "tablingMemberConstituency" : {"_value" : "Central Ayrshire"} , "tablingMemberPrinted" : [{"_value" : "Dr Philippa Whitford"} ], "uin" : "228683"} , {"_about" : "http://data.parliament.uk/resources/1082185", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1082185/answer", "answerText" : {"_value" : "
Individual medical schools set undergraduate medical training curricula and the relevant Royal Colleges set postgraduate medical training curricula which have to meet the standards set by the General Medical Council. Curricula should emphasise the skills and approaches that a doctor must develop in order to ensure accurate and timely diagnoses and treatment plans for their patients.<\/p>
<\/strong><\/p> The National Institute for Health and Care Excellence (NICE) published updated guidance in 2018 on the diagnoses and management of Lyme disease, which can be found at the following link:<\/p> <\/p> https://www.nice.org.uk/guidance/ng95<\/a><\/p> <\/p> The guidance aims to raise awareness of when Lyme disease should be suspected and ensure that people have prompt and consistent diagnosis and treatment. NICE\u2019s guidelines help health and care professionals deliver the best possible care based on the best available evidence. The guidelines are not mandatory, although health and care commissioners are expected to take them fully into account. In addition, in February 2019, NICE published the following article at the following link:<\/p> <\/p> https://www.nice.org.uk/news/article/diagnose-lyme-disease-if-bull-s-eye-rash-is-present-says-nice<\/a><\/p> <\/p> Public Health England published guidance on Lyme disease in July 2018, which describes the clinical signs and symptoms of Lyme disease and is consistent with the NICE guidance. The guidance can be found at the folloiwng link:<\/p> <\/p> https://www.gov.uk/government/collections/lyme-disease-guidance-data-and-analysis<\/a><\/p> <\/p> <\/p> <\/p> <\/strong><\/p>"}
, "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
, "dateOfAnswer" : {"_value" : "2019-03-11", "_datatype" : "dateTime"}
, "groupedQuestionUIN" : {"_value" : "228551"}
, "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
, "previousAnswerVersion" : {"_about" : "http://data.parliament.uk/resources/1082185/answer/previousversion/106916", "answeringMember" : {"_about" : "http://data.parliament.uk/members/4067", "label" : {"_value" : "Biography information for Steve Brine"}
}
, "answeringMemberConstituency" : {"_value" : "Winchester"}
, "answeringMemberPrinted" : {"_value" : "Steve Brine"}
}
, "questionFirstAnswered" : [{"_value" : "2019-03-11T18:29:30.3Z", "_datatype" : "dateTime"}
]}
, "answeringDeptId" : {"_value" : "17"}
, "answeringDeptShortName" : {"_value" : "Health and Social Care"}
, "answeringDeptSortName" : {"_value" : "Health and Social Care"}
, "date" : {"_value" : "2019-03-05", "_datatype" : "dateTime"}
, "hansardHeading" : {"_value" : "Lyme Disease"}
, "houseId" : {"_value" : "1"}
, "legislature" : [{"_about" : "http://data.parliament.uk/terms/25259", "prefLabel" : {"_value" : "House of Commons"}
}
], "questionText" : "To ask the Secretary of State for Health and Social Care, what recent assessment he has made of advances in the abilities of medical practitioners to diagnose Lyme Disease; and if he will make a statement.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
, "tablingMember" : {"_about" : "http://data.parliament.uk/members/253", "label" : {"_value" : "Biography information for Mr Laurence Robertson"}
}
, "tablingMemberConstituency" : {"_value" : "Tewkesbury"}
, "tablingMemberPrinted" : [{"_value" : "Mr Laurence Robertson"}
], "uin" : "228550"}
, {"_about" : "http://data.parliament.uk/resources/1082191", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
], "answer" : {"_about" : "http://data.parliament.uk/resources/1082191/answer", "answerText" : {"_value" : " Individual medical schools set undergraduate medical training curricula and the relevant Royal Colleges set postgraduate medical training curricula which have to meet the standards set by the General Medical Council. Curricula should emphasise the skills and approaches that a doctor must develop in order to ensure accurate and timely diagnoses and treatment plans for their patients.<\/p> <\/strong><\/p> The National Institute for Health and Care Excellence (NICE) published updated guidance in 2018 on the diagnoses and management of Lyme disease, which can be found at the following link:<\/p> <\/p> https://www.nice.org.uk/guidance/ng95<\/a><\/p> <\/p> The guidance aims to raise awareness of when Lyme disease should be suspected and ensure that people have prompt and consistent diagnosis and treatment. NICE\u2019s guidelines help health and care professionals deliver the best possible care based on the best available evidence. The guidelines are not mandatory, although health and care commissioners are expected to take them fully into account. In addition, in February 2019, NICE published the following article at the following link:<\/p> <\/p> https://www.nice.org.uk/news/article/diagnose-lyme-disease-if-bull-s-eye-rash-is-present-says-nice<\/a><\/p> <\/p> Public Health England published guidance on Lyme disease in July 2018, which describes the clinical signs and symptoms of Lyme disease and is consistent with the NICE guidance. The guidance can be found at the folloiwng link:<\/p> <\/p>